ResMed (RMD)
(Delayed Data from NYSE)
$272.60 USD
+1.41 (0.52%)
Updated Sep 16, 2025 03:59 PM ET
After-Market: $272.60 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth A Momentum A VGM
Fundamental Charts
About Market Cap
As of the previous market close, ResMed Inc. has a market cap of $39.71B, which represents its share price of $271.19 multiplied by its outstanding shares number of 146.41M. As a large-cap company, RMD's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
RMD 272.60 +1.41(0.52%)
Will RMD be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for RMD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RMD
Here's Why ResMed (RMD) is a Strong Growth Stock
Is it Worth Retaining ResMed Stock in Your Portfolio Now?
RMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why ResMed (RMD) is a Strong Growth Stock
Nyxoah Secures FDA Clearance for Genio System to Treat Sleep Apnea
Why ResMed (RMD) is a Top Momentum Stock for the Long-Term
Other News for RMD
Is RMD consolidating before a move? NR7 shows up after climbing 0.39%
UBS Keeps Their Buy Rating on Resmed (RMD)
Short bets on S&P 500 Healthcare sector eases in August; MRNA stays most shorted stock
UBS Keeps Their Buy Rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD)
ResMed participates in a conference call with KeyBanc